On November 9, GENSCRIPT B-1K rose 3.29% in Regular Trading, trading at HK$31.46, with turnover of HK$265 million.
The move came as Life Sciences Tools & Services names broadly advanced, with WUXI BIO up 5.0%, WUXI APPTEC up 3.51%, INSILICO up 4.91%, XTALPI up 4.08%, and PHARMARON up 4.6%, indicating a sector-led rebound.
Company-specific news remained centered on Legend Biotech, which said it plans to present two oral sessions, two posters, and one online publication on CARVYKTI at the ASH meeting in December. GENSCRIPT B-1K had also recently clarified unusual share-price volatility and market rumors around a trading-counter arrangement, stating that business operations remained normal. Taken together, the available information suggests the intraday rise aligns with a sector recovery, while investors continue to trade around upcoming CAR-T data disclosures.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments